GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » TruSpine Technologies PLC (AQSE:TSP) » Definitions » 14-Day RSI

TruSpine Technologies (AQSE:TSP) 14-Day RSI : 56.80 (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is TruSpine Technologies 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-23), TruSpine Technologies's 14-Day RSI is 56.80.

The industry rank for TruSpine Technologies's 14-Day RSI or its related term are showing as below:

AQSE:TSP's 14-Day RSI is ranked worse than
83.01% of 883 companies
in the Medical Devices & Instruments industry
Industry Median: 45.46 vs AQSE:TSP: 56.80

Competitive Comparison of TruSpine Technologies's 14-Day RSI

For the Medical Devices subindustry, TruSpine Technologies's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TruSpine Technologies's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TruSpine Technologies's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where TruSpine Technologies's 14-Day RSI falls into.



TruSpine Technologies  (AQSE:TSP) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TruSpine Technologies  (AQSE:TSP) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


TruSpine Technologies 14-Day RSI Related Terms

Thank you for viewing the detailed overview of TruSpine Technologies's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


TruSpine Technologies (AQSE:TSP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Af33 Beehive Ring Road, Spectrum House, London Gatwick Airport, London, GBR, RH6 0LG
TruSpine Technologies PLC is a medical device company. The company is engaged in the business of developing medical devices for spinal care. The product portfolio includes Cervi-LOK, GRASP Laminoplasty, and Faci-LOK.

TruSpine Technologies (AQSE:TSP) Headlines

No Headlines